Cancer

(HealthDay)—Night shift work may increase the risk for chronic lymphocytic leukemia (CLL), according to a study published online Jan. 13 in Occupational & Environmental Medicine.This article was originally published on MedicalXpress.com

(HealthDay)—A composite score can identify patients with chronic lymphocytic leukemia (CLL) with very low risk for requiring treatment, according to a study published online Jan. 14 in the European Journal of Haematology.This article was originally […]

Researchers at Barts Cancer Institute at Queen Mary University of London, supported by a partnership between the UK charities Worldwide Cancer Research and Pancreatic Cancer Research Fund, have made a discovery that reveals new insight […]

Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen receptor macrophage (CAR-M) has helped to establish the viability of this innovative immunotherapy, which advances […]

A moderate amount of a peptide-enhanced, biological cancer drug goes a long way in treating breast cancers that metastasize to the bone.This article was originally published on MedicalXpress.com

(HealthDay)—For patients with psoriasis, the risk for cancer is increased at the time of or after venous thromboembolism (VTE), according to a research letter published online Jan. 18 in the British Journal of Dermatology.This article […]

(HealthDay)—For patients with lymphoid malignancies undergoing autologous hematopoietic stem cell transplantation (aHSCT), frailty is associated with worse hospital outcomes, according to a study published online Dec. 23 in Clinical Lymphoma, Myeloma, & Leukemia.This article was […]

New research indicates that the COVID-19 pandemic has had a profound effect on pediatric oncology health care professionals worldwide, requiring significant staffing changes and causing physical, psychological, and financial distress. Published by Wiley online in Cancer, […]

Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment options are extremely limited.This article […]

In future, newly identified biomarkers could be used alongside imaging techniques for the non-invasive diagnosis of patients with advanced prostate cancer. A research team from the Medical University of Vienna and the Ludwig Boltzmann Institute […]